Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial

American Heart Journal

Volumn 175, Issue , 2016, Pages 86-93

  Berger, Jeffrey S ^a   Katona, Brian G ^b   Jones, W Schuyler ^c,d   Patel, Manesh R ^c,d   Norgren, Lars ^e   Baumgartner, Iris ^f   Blomster, Juuso ^g,h,i   Mahaffey, Kenneth W ^j   Held, Peter ^g   Millegård, Marcus ^g   Heizer, Gretchen ^d   Reist, Craig ^d   Fowkes, F Gerry ^k   Hiatt, William R ^l  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ASTRAZENECA   (United Kingdom)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e Örebro University   (Sweden)

^f UNIVERSITY OF BERN   (Switzerland)

^g ASTRAZENECA R AND D   (Sweden)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

ⁱ UNIVERSITY OF TURKU   (Finland)

^j STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; TICAGRELOR; ADENOSINE; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ANKLE BRACHIAL INDEX; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART INFARCTION; HUMAN; LEG ISCHEMIA; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RISK REDUCTION; STUDY DESIGN; THROMBOCYTE FUNCTION; AGED; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMPLICATION; FEMALE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; STROKE; TREATMENT OUTCOME;

ADENOSINE; AGED; ANKLE BRACHIAL INDEX; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; STROKE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84960083003     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2016.01.018     Document Type: Article

References (29)

1. F.G. Fowkes, D. Rudan, I. Rudan, and et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 382 2013 1329 1340
2. R. Pande, T. Perlstein, J. Backman, and et al. Secondary prevention and mortality in peripheral arterial disease: National Health and Nutrition Examination Study, 1994 to 2004 Circulation 124 2011 17 23
3. L. Norgren, W.R. Hiatt, J.A. Dormandy, and et al. Inter-society consensus for the management of peripheral arterial disease (TASC II) Vasc Surg 45 Suppl. S 2007 S5 S67
4. T.W. Rooke, A.T. Hirsch, S. Misra, and et al. Focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 2020 2045
5. M. Tendera, V. Aboyans, M.L. Bartelink, and et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2851 2906
6. J.S. Berger, M.J. Krantz, J.M. Kittelson, and et al. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials JAMA 301 2009 1909 1919
7. J. Belch, A. MacCuish, I. Campbell, and et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease BMJ 337 2008 a1840
8. F.G. Fowkes, J.F. Price, M.C. Stewart, and et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial JAMA 303 2010 841 848
9. W.R. Hiatt, J. Goldstone, S.C. Smith Jr., and et al. Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases Circulation 118 2008 2826 2829
10. CAPRIE Steering Committee A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
11. P.P. Cacoub, D.L. Bhatt, P.G. Steg, and et al. Patients with peripheral arterial disease in the CHARISMA trial Eur Heart J 30 2009 192 201
12. P. Alonso-Coello, S. Bellmunt, C. McGorrian, and et al. Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2 Suppl. 2012 e669S e690S
13. L. Wallentin, R.C. Becker, A. Budaj, and et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
14. M.R. Patel, R.C. Becker, D.M. Wojdyla, and et al. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: data from the PLATO Trial Eur J Prev Cardiol 22 2015 734 742
15. M.P. Bonaca, D.L. Bhatt, M. Cohen, and et al. Long-term use of ticagrelor in patients with prior myocardial infarction N Engl J Med 372 2015 1791 1800
16. A study comparing cardiovascular effects of ticagrelor and clopidogrel in patients with peripheral artery disease (EUCLID) ClinicalTrials.gov identifier: NCT01732822. Available at https://clinicaltrials.gov/ct2/show/NCT01732822 Accessed June 8, 2015
17. M.A. Espeland, J.G. Regensteiner, S.A. Jaramillo, and et al. Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes study Vasc Med 13 2008 225 233
18. V. Aboyans, M.H. Criqui, P. Abraham, and et al. Measurement and interpretation of the ankle-brachial index Circulation 126 2012 2890 2909
19. S. Husted, H. Emanuelsson, S. Heptinstall, and et al. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin Eur Heart J 27 2006 1038 1047
20. C.P. Cannon, S. Husted, R.A. Harrington, and et al. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial J Am Coll Cardiol 50 2007 1844 1851
21. M.P. Bonaca, B.M. Scirica, M.A. Creager, and et al. Vorapaxar in patients with peripheral artery disease: results from TRA2°P-TIMI 50 Circulation 127 2013 1522 1529
22. D.L. Bhatt, K.A. Fox, W. Hacke, and et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
23. J. Ostergren, P. Sleight, G. Dagenais, and et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease Eur Heart J 25 2004 17 24
24. D.L. Bhatt, P.G. Steg, E.M. Ohman, and et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis JAMA 295 2006 180 189
25. P.P. Cacoub, M.T. Abola, I. Baumgartner, and et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry Atherosclerosis 204 2009 e86 e92
26. M. Monreal, L. Alvarez, B. Vilaseca, and et al. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA) Eur J Intern Med 19 2008 192 197
27. J.P. Cambou, V. Aboyans, J. Constans, and et al. Characteristics and outcome of patients hospitalized for lower extremity peripheral artery disease in France: the COPART Registry Eur J Vasc Endovasc Surg 39 2010 577 585
28. D.L. Bhatt, E.D. Peterson, R.A. Harrington, and et al. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes Eur Heart J 30 2009 1195 1202
29. J.S. Berger, and W.R. Hiatt Medical therapy in peripheral artery disease Circulation 126 2012 491 500